Trial NCT01659099

View at ClinicalTrials.gov 
Org. Study IDs: GAINED

Last trial update was posted on 2018-03-07

MeSH Interventions

Bleomycin Cyclophosphamide Doxorubicin Obinutuzumab Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B Cell Lymphoma CD20 Positive

Stopping Reasons

experimental treatment not Superior to standard - no need to continue the follow-up

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID